Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Esomeprazole
2. Esomeprazole Magnesium
3. Esomeprazole Potassium
4. Esomeprazole Sodium
5. Esomeprazole Strontium Anhydrous
6. Nexium
7. Strontium, Esomeprazole
1. S-omeprazole Strontium Hydrate
2. Fm0f67
3. Esomeprazole Strontium [usan]
4. 934714-36-0
5. Fm-0f67
6. C5n25h3803
7. (-)-5-methoxy-2-((s)-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1h- Benzimidazole Strontium Salt Tetrahydrate
8. 1h-benzimidazole, 6-methoxy-2-((s)-((4-methoxy-3,5-dimethyl-2-pyridinyl) Methyl)sulfinyl)-, Strontium Salt, Hydrate (2:1:4)
9. Esomeprazole Strontium (usan)
10. Strontium;5-methoxy-2-[(s)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;tetrahydrate
11. Unii-c5n25h3803
12. Esomeprazole Strontium (tn)
13. Esomeprazole Strontium Hydrate
14. Chembl2146140
15. Hip1601
16. Esomeprazole Strontium Tetrahydrate
17. Hip-1601
18. Esomeprazole Strontium [vandf]
19. Esomeprazole Strontium [usp-rs]
20. Esomeprazole Strontium [who-dd]
21. Esomeprazole Strontium [orange Book]
22. Esomeprazole Strontium [usp Monograph]
23. D10120
24. Q27275225
Molecular Weight | 848.5 g/mol |
---|---|
Molecular Formula | C34H44N6O10S2Sr |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 10 |
Exact Mass | 848.16164622 g/mol |
Monoisotopic Mass | 848.16164622 g/mol |
Topological Polar Surface Area | 167 Ų |
Heavy Atom Count | 53 |
Formal Charge | 0 |
Complexity | 453 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 7 |
1 of 2 | |
---|---|
Drug Name | Esomeprazole strontium |
PubMed Health | Esomeprazole |
Drug Classes | Gastric Acid Secretion Inhibitor, Gastrointestinal Agent |
Drug Label | The active ingredient in the proton pump inhibitor esomeprazole strontium delayed-release capsules is bis(5methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-1-yl)strontium tetrahydrate. Esomeprazole is the S... |
Active Ingredient | Esomeprazole strontium |
Dosage Form | Capsule, delayed release |
Route | Oral |
Strength | eq 40mg base; eq 20mg base |
Market Status | Prescription |
Company | Hanmi Pharm |
2 of 2 | |
---|---|
Drug Name | Esomeprazole strontium |
PubMed Health | Esomeprazole |
Drug Classes | Gastric Acid Secretion Inhibitor, Gastrointestinal Agent |
Drug Label | The active ingredient in the proton pump inhibitor esomeprazole strontium delayed-release capsules is bis(5methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole-1-yl)strontium tetrahydrate. Esomeprazole is the S... |
Active Ingredient | Esomeprazole strontium |
Dosage Form | Capsule, delayed release |
Route | Oral |
Strength | eq 40mg base; eq 20mg base |
Market Status | Prescription |
Company | Hanmi Pharm |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?